Apigenin attenuates myocardial ischemia-reperfusion injury through miR-448/SIRT1 axis

Objective(s): Myocardial ischemia/reperfusion injury (MIRI) is the primary pathological injury following ischemic cardiomyocyte therapy, but there are few effective treatments available for MIRI. Apigenin (API) is an active ingredient of herbal medicine. Our study aims to verify whether API regulate...

Full description

Saved in:
Bibliographic Details
Main Authors: Chenchen Tian, Bo Yu, Yibo Liu, Zhipeng Diao, Yue Wang, Jianmei Zhou
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2025-05-01
Series:Iranian Journal of Basic Medical Sciences
Subjects:
Online Access:https://ijbms.mums.ac.ir/article_25492_1ab7879234b7b6d0f9e31999ed188849.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!